ZnI

Akihiro Ishiwata, Xuemei Zhong, Katsunori Tanaka, Yukishige Ito, Feiqing Ding

Abstract readReview

In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Akihiro IshiwataRIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.ORCID 0000-0002-5542-2214

Xuemei ZhongSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.

Katsunori TanakaRIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.

Yukishige ItoRIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.

Feiqing DingSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.ORCID 0000-0002-0211-7101

Funding

Guangdong Basic and Applied Basic Research Funding 2024A1515010015Japan Society for the Promotion of Science JP19H00929, JP24K01704, JP22H02196, JP24H02269Shenzhen Science and Technology Program GJHZ20220913142602004

6 · The paper itself

Abstract

An efficient and versatile glycosylation methodology is crucial for the systematic synthesis of oligosaccharides and glycoconjugates. A direct intermolecular and an indirect intramolecular methodology have been developed, and the former can be applied to the synthesis of medium-to-long-chain glycans like that of nucleotides and peptides. The development of a generally applicable approach for the stereoselective construction of glycosidic bonds remains a major challenge, especially for the synthesis of 1,2-

Indexed as

1,2-cis-glycosideconstrained glycosyl donorsoligosaccharidesstereoselective cis-glycosylationZnI2

Identifiers

PMID39407638

DOI10.3390/molecules29194710

PMCPMC11477539

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.